EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it and its subsidiary, Aurinia Pharma U.S., Inc., (collectively, “Aurinia”) have entered into a settlement agreement with Teva Pharmaceuticals Inc. (“Teva”) to resolve patent infringement litigation relating to Teva’s filing of an Abbreviated New Drug Application seeking to market its generic 7.9 mg voclosporin…
Hannah’s cousin died and she didn’t have to. Wormhole investigates the dark world of alternative wellness online – and the comforts and dangers of such communities.
Moderna and Merck shares soared on Wednesday after the companies said a personalized mRNA treatment hit its target of preventing skin cancer from recurring or spreading in a late-stage clinical trial.
A human multi-organ chip models how breast cancer spreads from blood vessels to bone and lung, offering a patient-specific tool to study metastasis and potential treatments.
Health-e News Learners and kitchen staff fall sick as sewage surrounds Soshanguve school feeding scheme For the past five years, more than 800 learners and staff at Seetsa sa Kgwedi Primary School in…
